Patient-centered drug development and the Learning Health System

Erin Moore e.keeleymoore@gmail.com
Leigh Anne Naas naasla@lilly.com
Laura Crawford crawford_laura@lilly.com

Abstract

Patient-centered drug development (PCDD) is a shift in the way drugs are developed, systematically incorporating patient participation in all stages of medicine development. We will discuss how the Learning Health System can facilitate PCDD by connecting stakeholders and enabling efficient flow of data, information, and evidence in the health ecosystem.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search